IGF-1 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-11-23. Where a claim depends on a specific study, the study is described rather than over-claimed.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 44-residue GHRH analog | Sequence matches human GHRH(1-44); differs only at the N-terminus |
| Nominal molecular mass | Approximately 5,136 Da (free base) | Small variation arises from counterion and salt form |
| Appearance | White to off-white lyophilized powder | Supplied in single-use vials intended for reconstitution |
| Solubility class | Freely soluble in water | Practically insoluble in nonpolar organic solvents |
| Typical storage | 2 to 8 degrees Celsius, protected from light | Reconstituted material is handled according to label instructions |
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
tesamorelin 是一种人工合成的四十四肽，序列与内源性生长激素释放激素（GHRH）的 1-44 片段一致，区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割，从而延长分子在循环中的存留时间。作为肽类分子，它难以经胃肠道吸收，文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物，以区别于生长激素本身。
特沙莫瑞林是一种合成肽，其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰，这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂，可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物，而非小分子化合物。
监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。
In 2013, Xi announced the Belt and Road Initiative (BRI), a global infrastructure and economic development project. Encompassing much of Africa and Eurasia, the BRI became central to Chinese foreign policy and is the largest infrastructure investment by a great power since the Marshall Plan. In 2015, Xi announced the founding of the Asia Infrastructure Investment Bank, seen as a competitor to other multilateral banks such as the World Bank and the Asia Development Bank. Xi has unveiled the Global Development Initiative (GDI), the Global Security Initiative (GSI), the Global Civilisation Initiative (GCI), and the Global Governance Initiative (GGI) in 2021, 2022, 2023 and 2025 respectively, aiming to increase China's influence in the international order. Under Xi, China has, along with Russia, also focused on increasing relations with the Global South in order to blunt the effect of international sanctions.
=== 1960–1995 === Originally founded as Metropolitan Pathology Laboratory, Inc. in 1967 by Paul A. Brown, MD, the clinical laboratory underwent a variety of name changes. In 1969, the company's name changed to MetPath, Inc. with headquarters in Teaneck, New Jersey. By 1982, MetPath was acquired by what was then known as Corning Glass Works and was subsequently renamed Corning Clinical Laboratories.
Cyproterone acetate (CPA), sold alone under the brand name Androcur or with ethinylestradiol under the brand names Diane or Diane-35 among others, is an antiandrogen and progestin medication used in the treatment of androgen-dependent conditions such as acne, excessive body hair growth, early puberty, and prostate cancer, as a component of feminizing hormone therapy for transgender individuals, and in birth control pills. It is formulated and used both alone and in combination with an estrogen. CPA is taken by mouth one to three times per day.
=== Pharmacokinetics === Ceftolozane–tazobactam is available as a 2:1 fixed combination (such that a 1.5 g dose of ceftolozane–tazobactam is composed of 1 g of ceftolozane and 500 mg of tazobactam). Ceftolozane-tazobactam is administered intravenously. For both ceftolozane and tazobactam, the peak plasma concentration occurs immediately after a 60 minute infusion, with a time to maximum concentration of approximately one hour. The binding of ceftolozane to human plasma proteins is approximately 16% to 21%, while the binding of tazobactam is approximately 30%. The mean steady-state volume of distribution in healthy adult males after a single 1.5 g IV dose is 13.5 L for ceftolozane and 18.2 L for tazobactam, which is similar to extracellular fluid volume. Tissue distribution of ceftalozone-tazobactam is rapid and shows good penetration into the lung, rendering it an ideal treatment for bacterial pneumonia. The metabolism and excretion of ceftolozane are similar to those of most β-lactam antimicrobial agents. Ceftolozane is not metabolized to any significant extent and thus predominantly eliminated unchanged in the urine. Tazobactam is partially metabolized to an inactive metabolite, and both drug and metabolite are excreted in the urine (80% as unchanged drug). The half-life of ceftolozane is 2.5–3.0 hours, and the half-life of tazobactam is approximately 1.0 hour; the clearance of both drugs is directly proportional to renal function. Tazobactam primarily undergoes renal excretion via active tubular secretion.
Synthetic Fe–S clusters are laboratory-prepared coordination compounds or chains, often designed to mimic the structural, electronic, or chemical properties of biological Fe–S clusters. Roussin's black anion, [Fe4S3(NO)7]−, described in 1858, is the first synthetic Fe-S cluster. It has the geometry of an incomplete cubane-type cluster with C3v symmetry. The dark color of the complex is attributed to a number of charge-transfer interactions. Since the 1970s, many of these Fe-S clusters have been described. A key property of Fe–S clusters is their ability to undergo redox.
Sources: en.wikipedia.org
Algae ( AL-jee, UK also AL-ghee; sing.: alga ) are any of a large and diverse group of photosynthetic organisms. It excludes the land plants (embryophytes). Such organisms range from microscopic unicellular microalgae (including cyanobacteria and phytoplankton) to seaweeds, multicellular macroalgae which may grow up to 50 metres (160 ft) in length. Most algae are aquatic (especially marine), and some form cohesive colonies. Freshwater algae include Charophyta such as the filamentous Spirogyra and the grasslike stoneworts. Most algae are plankton carried passively by water, although some macroalgae have holdfasts for anchorage. Algae are polyphyletic as they have multiple evolutionary origins. Although algae with two-membraned chloroplasts seem to form a paraphyletic group within the clade Archaeplastida, other algae with chloroplasts that have three or more membranes evolved from protists that acquired photosynthesis after engulfing archaeplastids. Chlorophytes, rhodophytes (red algae) and glaucophytes (grey algae) have primary chloroplasts directly derived from endosymbiont cyanobacteria, while diatoms, cryptomonads, euglenoids and phaeophyceae (brown algae) have secondary chloroplasts derived from indirectly endosymbiont red algae or green algae. Most algae are single-celled organisms without roots, leaves, or stems. Most are photoautotrophs and the main primary producers of aquatic ecosystems, although some are mixotrophs that derive metabolic energy both from internal photosynthesis and from foraging external nutrients.
Surface embalming, another supplemental method, utilizes embalming chemicals to preserve and restore areas directly on the skin's surface and other superficial areas as well as areas of damage such as from accident, decomposition, cancerous growths, or skin donation. There are many further miscellaneous procedures. For example, pacemakers are required to be removed if the body is to be cremated as the battery inside can explode and damage the cremator. Such are removed with one incision over the device, after which it may be extracted and discarded of properly. Surgical incisions are treated depending on their location and stage of healing. If the sutures are recent, a solution of phenol or other preservative chemicals is injected into the margins and the area disinfected. Metal sutures are removed after arterial injection, and the incision then tightly sutured with a running stitch. Sealing powder can be applied to protect against leakage, and glue is then applied over the surface of the incision. If the suture is visible, cyanoacrylate and/or a restorative suture is used. For feeding and breathing tubes, the skin around them may be destroyed and dented, and an embalmer may choose to use tissue builder or wax filler to restore the look and contour of the skin. Tracheotomy holes are left until after embalming as an outlet for purge before being permanently sealed, though they are closed with a saturated cotton ball to disinfect the opening and to contain any leakage during the arterial injection.
=== Classical antiquity === Greco-Roman accounts of what we now know as diabetes primarily describe excessive urination (polyuria). There is no known account of sweetness in early Greco-Roman concepts of the disease. Given the lasting legacy of classical medicine, these descriptions remained highly influential into the Middle Ages in Europe.
=== Thyroxine, iodine and apoptosis === Thyroxine and iodine stimulate the apoptosis of the cells of the larval gills, tail and fins in amphibian metamorphosis, and stimulate the evolution of their nervous system transforming the aquatic, vegetarian tadpole into the terrestrial, carnivorous frog. In fact, amphibian frog Xenopus laevis serves as an ideal model system for the study of the mechanisms of apoptosis.
Sources: en.wikipedia.org
=== 1951 === January 4: Chinese soldiers capture Seoul. March 14: United Nations forces recapture Seoul during Operation Ripper. By the end of March, they have reached the 38th Parallel, and formed a defensive line across the Korean Peninsula. March 29: Julius and Ethel Rosenberg are convicted of espionage for their role in passing atomic secrets to the Soviets during and after World War II; they were executed on June 19, 1953. April 11: U.S. President Harry S. Truman fires Douglas MacArthur from command of US forces in Korea due to him demanding nuclear weapons to be used on the enemy. April 18: The European Coal and Steel Community is formed by the Treaty of Paris. April 23: American journalist William N. Oatis is arrested in Czechoslovakia for alleged espionage. May 23: The Seventeen Point Agreement is signed between Tibet and the People's Republic of China, formally annexing Tibet into China itself. September 1: Australia, New Zealand, and the United States sign the ANZUS Treaty. This compels the three countries to cooperate on matters of defense and security in the Pacific. October 10: President Harry S. Truman signs the Mutual Security Act, announcing to the world, and its communist powers in particular, that the U.S. was prepared to provide military aid to "free peoples". November 14: President Harry Truman asks Congress for U.S. military and economic aid for the communist nation of Yugoslavia. December 12: The International Authority for the Ruhr lifts part of the remaining restrictions on German industrial production and on production capacity.
Between 11% and 27% of cases of keratoconus will progress to a point where vision correction is no longer possible, thinning of the cornea becomes excessive, or scarring as a result of contact lens wear causes problems of its own, and a corneal transplantation or penetrating keratoplasty becomes required. Keratoconus is the most common grounds for conducting a penetrating keratoplasty, generally accounting for around a quarter of such procedures. The corneal transplant surgeon trephines a lenticule of corneal tissue and then grafts the donor cornea to the existing eye tissue, usually using a combination of running and individual sutures. The cornea does not have a direct blood supply, so the donor tissue is not required to be blood type matched. Eye banks check the donor corneas for any disease or cellular irregularities. The acute recovery period can take four to six weeks, and full postoperative vision stabilization often takes a year or more, but most transplants are very stable in the long term. The National Keratoconus Foundation reports that penetrating keratoplasty has the most successful outcome of all transplant procedures, and when performed for keratoconus in an otherwise healthy eye, its success rate can be 95% or greater. The sutures used usually dissolve over a period of three to five years, but individual sutures can be removed during the healing process if they are causing irritation to the person. In the US, corneal transplants (also known as corneal grafts) for keratoconus are usually performed under sedation as outpatient surgery.
== Related compounds == Later work showed that replacing the chlorine atom with a fluorine atom (2F-Viminol) or with a trifluoromethyl group produced a compound with twice the potency and half the acute toxicity. A later team at Zambon found that one isomer of a pyrrolidone analog is 318 times as potent as morphine in its analgesic activity in animal studies. A number of related compounds were also found to be active, allowing a QSAR model to be constructed.
Sources: en.wikipedia.org
It is a synthetic peptide built from 44 amino acids arranged in the same order as human growth hormone-releasing hormone. A short fatty-acid chain, described as a trans-3-hexenoyl group, is attached to the first amino acid. The finished molecule is formulated as a sterile powder that is dissolved before use.
No. It is a releasing-factor analog that signals the pituitary gland to secrete growth hormone, whereas recombinant growth hormone is the hormone itself administered directly. The two are chemically distinct and act at different points in the same endocrine pathway. This distinction is often lost in informal discussion.
Native growth hormone-releasing hormone is broken down within minutes by dipeptidyl peptidase-4 in the bloodstream. Adding the hexenoyl group at the N-terminus shields the peptide from that enzyme. The modification does not change the receptor it targets, only how long the peptide survives in circulation.
The amino acid sequence matches human growth hormone-releasing hormone, but the amino terminus carries a trans-3-hexenoyl group instead of a free amine. That single structural change chiefly affects enzymatic stability rather than receptor selectivity.